Publication | Open Access
<i>Xenopus</i>‐derived glucagon‐like peptide‐1 and polyethylene‐glycosylated glucagon‐like peptide‐1 receptor agonists: long‐acting hypoglycaemic and insulinotropic activities with potential therapeutic utilities
20
Citations
27
References
2017
Year
Peptide 33 is a promising long-acting type 2 diabetes therapeutic deserving further investigation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1